# Xenon pauses phase 3 depression trials after psychosis events

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-19 04:29 UTC · Category: Business · Sources: 6 · Current Velocity: 4.29

## Key People, Organizations & Locations
Xenon

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioPharma Dive | Xenon shares fall following depression trial pause | 2026-09-18 10:03 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxNTjBZU2JQRlRtWUh2S2lEOXRwOUtDNUpUdWFQQTdvRFpBSzdJQjBoLWQ3RU96Y3B2ZzREWmdTNzNaWDBmcklmWVhJaWQtNnAwa0N6YTRrNDlfVF9nTzIyNDZMTHZlanpnWmVuaXFKV3NNRTZMbnB5cXRYZy1PUU5ybVJBZmpJUnBmeE5pSGxhNEgtMTE4a1lDRV9wWnF5dw?oc=5) |
| Yahoo Finance | Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program | 2026-09-18 10:03 | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxQcmRzbUFBU0VyWFgyUll3R1A3TEVXdTlaY0YwZEMtRWhSTURraXczVVF3UTFfZzh1WTVVSDFaTC11dUprU2p0NUg0Y1ZOdmY1QV9FRUREOFpSUGhOZGF5Q1V4UUdtUHowRUNkbm9xaUl1Zm84dENFUjYyeEtzLUlhdnpDbTJ4bkVwbHlJSFVTU1o0eFB3MGwzV0FERE8wRXVZR3JJM0pn?oc=5) |
| Investor's Business Daily | Why This Biotech Just Erased Its One-Day 50% Pop | 2026-09-18 10:03 | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxOOC1ZSGdGaGdad2pRSGpDNkZ5TDR1c205R1BfMDBOMl9zaXpoRy1BQkpNOUl5YkVXc2VubGgxWXNSUnNUbkd4TVZFZTJwc251SEtKVHpnR1NZWE1aOU51dE05M0t2ekVUZTh2ODIyTFl3UGNOem5OY25ITjBpUFZuYUlKZ2Y5WXdjZDJjZzZoSUd6NkZtdmJuSFp5QllXUjhzbUJHTVBR?oc=5) |
| Barron's | Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain. | 2026-09-18 10:03 | [Source Link](https://news.google.com/rss/articles/CBMieEFVX3lxTFBidmIxaERSLTRJZHZVUXp5cV9ib3l3VE9fTWtVakZjMW9PUmFkUmtSbGcwOFpvZmxuUzR2WFBoQ3UxY1BOWU5BOHNrZ3pfZF95N2pGMzFkcWZFMXJpY3BGZXJDQk0wOEczbU14TlZkNWZxVGtWRzJ0ZQ?oc=5) |
| Yahoo Finance | XENE Files NDA for Epilepsy Drug, Falls on Depression Studies' Setback | 2026-09-18 10:03 | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxOVDZjTWlLdDFicUtvQXlQVERBRGZoRi1QTVEzQ0tTUUx6aE5qY05Na1ROZV9LRzlZdUdMZkQ2TGlreEsxOUhyR2NmRlhkR1dESm9WYk9fQjJjRlFXRi1yeEdTMVVhU0RRUGVsZzUtMnEzQ0QtWjBfRk04UzRLUzFvUkkzSHdLaGRzcWl3bzRJTG43WkE?oc=5) |
| Reuters | Xenon pauses new enrollment in depression drug trials over side-effect concerns | 2026-09-18 10:03 | [Source Link](https://news.google.com/rss/articles/CBMi5gFBVV95cUxPYS1ySjRBMG5zZU5LMDhnQ1RtZV92ZElWUjhtZ2g1QlFXY1JLamRFejN5XzJhVWdUWjE5ODhjRFFuX1I3WEV0RVFlRG43dFl5c3hld1QzN3VWX25TOGppQVpaYjA5ODFjVmlmMDlUZFNLbklKTm1NY2lEVUlLM2VPbkFMR3Y5WXpaS2hZcmgtdUhyTmxFWG9SVmdwandGN0NiX3VnRU05dUZqUE8yRVc0d2JfeVZCNmhmWHRkYUJpNExtREx3U0hVY0Z3YjRIUkNVV2lxU3BIeE5wYVQ2NFdrQzR5ckkwZw?oc=5) |
| fiercebiotech.com | Xenon pauses phase 3 depression trials after psychosis events | 2026-09-18 10:03 | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxQMnNqUWp5TG9MdGtwLTFOLU5xa3VVdXlDRFM4dHQyUDBrdVc1WVZ6RjBidWpsMEF1RkFBb2ZIUGwyQjlCVzJSTnp2UlBkcEs3OGUzWTY2dGZQNXZ5OE9VMThqVEJyck1WbWlWTjBOTTBVQVZ1emJTckJxR3JWTEpYYldZLXFCdzR5cG9xeTRlSElTN0tSZVJfT0hTeWw4ZTlZ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-19/xenon-pauses-phase-3-depression-trials-after-psychosis-events*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*